Lam Research Corp. 10-Q Summary: Quarter Ended March 31, 1999
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 1999 (the third quarter of fiscal year 1999) and the nine months ended March 31, 1999. Lam Research Corporation designs, manufactures, and markets semiconductor processing equipment, primarily focusing on etch and Chemical Mechanical Planarization (CMP) systems. The company is navigating a severe global slowdown in the semiconductor equipment industry characterized by depressed DRAM pricing and production overcapacity.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Mar 31, 1999 | Nine Months Ended Mar 31, 1999 | Mar 31, 1999 Balance Sheet |
|---|---|---|---|
| Total Revenue | $152,976 | $437,070 | - |
| Gross Margin | $54,302 (35.5%) | $151,550 (34.7%) | - |
| Operating Loss | $(14,624) | $(124,268) | - |
| Net Loss | $(14,724) | $(124,262) | - |
| Net Loss Per Share (Basic/Diluted) | $(0.38) | $(3.23) | - |
| Cash & Cash Equivalents | - | - | $73,049 |
| Short-term Investments | - | - | $229,763 |
| Total Debt (Current + Long-term) | - | - | $345,035 |
| Working Capital | - | - | $516,411 |
Note: Gross margin for the three months ended March 31, 1999, includes a $19.6 million restructuring charge within Cost of Goods Sold.
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 36% for the quarter and 47% for the nine-month period compared to the prior year, driven by decreased demand across all product lines.
- Restructuring Charges: The company recorded a $53.4 million restructuring charge in the nine months ended March 31, 1999 (including $19.6 million in COGS and $33.8 million in SG&A). This was part of a broader effort to reduce workforce and exit Flat Panel Display (FPD) and Chemical Vapor Deposition (CVD) operations.
- Margin Compression: Gross margin percentage declined to 35.5% for the quarter (from 36.5% in the prior year) due to competitive pricing pressures and lower sales volume, though it improved sequentially from 33.2% in the prior quarter.
- Expense Reduction: R&D expenses decreased 26.8% and SG&A expenses decreased 30.2% year-over-year for the quarter, reflecting cost management initiatives.
- Cash Flow: Net cash used in operating activities was $55.4 million for the nine months, compared to $24.1 million in the prior year period. Investing activities provided $128.7 million primarily from the net sale of short-term investments.
Guidance, Outlook, and Risks
- Outlook: Management anticipates increased demand for systems as semiconductor manufacturers ramp capacity in advanced lines. Net sales are expected to increase sequentially in the fourth quarter of fiscal 1999.
- Liquidity: The company holds $354.2 million in cash, cash equivalents, short-term investments, and restricted cash. It has a $100 million syndicated bank line of credit with no borrowings outstanding. Management considers these resources adequate for at least the next twelve months.
- Restructuring Status: Approximately $34.5 million of restructuring reserves remain accrued as of March 31, 1999, with future cash payments expected to continue into fiscal 2000.
- Year 2000 Compliance: The company is actively addressing Y2K issues for internal systems and customer products. Estimated total program costs are less than $5 million, with most expected to be offset by upgrade revenues.
- Risk Factors: Key risks include continued volatility in the semiconductor industry, dependence on a limited number of high-priced products, intense competition (particularly in the new CMP market), and potential disruptions from international economic conditions (specifically in Asia).
Investor Verification Checklist
- Verify the sequential revenue growth trend in the fourth quarter of fiscal 1999 to confirm the anticipated recovery.
- Monitor the execution of restructuring plans and the actual cash outflows against the $34.5 million accrued liability.
- Assess the market acceptance and revenue contribution of the new Teres(TM) CMP system amidst competition from Applied Materials and others.
- Review the impact of Asian economic conditions on international sales, which accounted for 51% of revenue in the first nine months.
- Confirm the status of the Varian Associates patent litigation and any potential financial exposure.